Correlation Between Biotechnology Portfolio and Fidelity Advisor

Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Fidelity Advisor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Fidelity Advisor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Fidelity Advisor Technology, you can compare the effects of market volatilities on Biotechnology Portfolio and Fidelity Advisor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Fidelity Advisor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Fidelity Advisor.

Diversification Opportunities for Biotechnology Portfolio and Fidelity Advisor

-0.46

Correlation Coefficient

Biotechnology Portfolio  Fidelity Advisor

Very good diversification

The 3 months correlation between Biotechnology and Fidelity is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Fidelity Advisor Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Advisor Tec and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Fidelity Advisor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Advisor Tec has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Fidelity Advisor go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Fidelity Advisor

Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to under-perform the Fidelity Advisor. But the mutual fund apears to be less risky and, when comparing its historical volatility, Biotechnology Portfolio Biotechnology is 1.2 times less risky than Fidelity Advisor. The mutual fund trades about 0.0 of its potential returns per unit of risk. The Fidelity Advisor Technology is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  13,380  in Fidelity Advisor Technology on September 23, 2024 and sell it today you would earn a total of  1,396  from holding Fidelity Advisor Technology or generate 10.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biotechnology Portfolio Biotec  vs.  Fidelity Advisor Technology

Biotechnology Portfolio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Fidelity Advisor Tec

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Advisor Technology are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Fidelity Advisor may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Biotechnology Portfolio and Fidelity Advisor

The main advantage of trading using opposite Biotechnology Portfolio and Fidelity Advisor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Fidelity Advisor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Advisor will offset losses from the drop in Fidelity Advisor's long position.

The idea behind Biotechnology Portfolio Biotechnology and Fidelity Advisor Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.